Table 1

Baseline patient characteristics

n (%)
Age (yr)
Median58.5
Range49–74
Gender
Male17 (71)
Female7 (29)
KPSa
90–10012 (50)
70–8012 (50)
Prior therapy
Surgery18 (75)
Radiotherapy23 (96)
Chemotherapy16 (67)
≤2 modalities21 (88)
≥3 modalities13 (54)
Location of recurrence
Cervical (including lymph node)15 (63)
Oropharynx3 (13)
Other6 (24)
Tumor size (max. diameter, cm)
Mean3.4 (±2.1)
Median3.38
Range1.0–7
Baseline neutralizing antibody levels
<1:2010 (42)
≥1:2014 (58)
CD4 cell counts (cells/μl)
Median339
Range126–1318
p53 gene status
Mutant12
Wild-type7
Indeterminant5
  • a KPS, Karnofsky performance status; max., maximal.